Performances of Functional and Anatomic Imaging Modalities in Succinate Dehydrogenase A- Related Metastatic Pheochromocytoma and Paraganglioma
- PMID: 36010880
- PMCID: PMC9406057
- DOI: 10.3390/cancers14163886
Performances of Functional and Anatomic Imaging Modalities in Succinate Dehydrogenase A- Related Metastatic Pheochromocytoma and Paraganglioma
Abstract
The study identifies the importance of positron emission tomographic (PET) and anatomic imaging modalities and their individual performances in detecting succinate dehydrogenase A (SDHA)-related metastatic pheochromocytoma and paraganglioma (PPGL). The detection rates of PET modalities-68Ga-DOTATATE, 18F-FDG, and 18F-FDOPA-along with the combination of computed tomography (CT) and magnetic resonance imaging (MRI) are compared in a cohort of 11 patients with metastatic PPGL in the setting of a germline SDHA mutation. The imaging detection performances were evaluated at three levels: overall lesions, anatomic regions, and a patient-by-patient basis. 68Ga-DOTATATE PET demonstrated a lesion-based detection rate of 88.6% [95% confidence interval (CI), 84.3-92.5%], while 18F-FDG, 18F-FDOPA, and CT/MRI showed detection rates of 82.9% (CI, 78.0-87.1%), 39.8% (CI, 30.2-50.2%), and 58.2% (CI, 52.0-64.1%), respectively. The study found that 68Ga-DOTATATE best detects lesions in a subset of patients with SDHA-related metastatic PPGL. However, 18F-FDG did detect more lesions in the liver, mediastinum, and abdomen/pelvis anatomic regions, showing the importance of a combined approach using both PET modalities in evaluating SDHA-related PPGL.
Keywords: 18F-FDG; 68Ga-DOTATATE; CT; MRI; PET; SDHA; metastatic; paraganglioma; pheochromocytoma.
Conflict of interest statement
The authors declare no perceived conflict of interest.
Figures
References
-
- Amar L., Pacak K., Steichen O., Akker S.A., Aylwin S.J.B., Baudin E., Buffet A., Burnichon N., Clifton-Bligh R.J., Dahia P.L.M., et al. International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers. Nat. Rev. Endocrinol. 2021;17:435–444. doi: 10.1038/s41574-021-00492-3. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources